web counter

Old diabetes drug given new life as potential cancer treatment

Phenformin, discontinued in the 1970s as a diabetes treatment, is now being investigated as an adjunct to cancer immunotherapies

A new review article published in the journal Trends in Cancer is presenting a promising case for phenformin, an old diabetes drug related to metformin, being repurposed as an adjunct to new immunotherapy cancer treatments. A phase 1 clinical trial is already underway to test the safety of the combination treatment for skin cancer.

Continue Reading

Category: Medical, Science

Tags: , , , ,